Delivery Order SPE2DB20D1100-SPE2DB25FE1KB
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $63K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Feraheme 510 mg/17 ml vials, with a ceiling value of $4,478.39. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,299.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 25, 2025, with an ultimate completion date of September 26, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.44 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 10, 2025, with completion expected by September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $6,598.26 to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 mL vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Feraheme is an iron replacement therapeutic used in medical treatment, and this delivery order fulfills a specific...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Feraheme 510 mg/17 mL vials. This non-set-aside, competitively awarded contract carries a ceiling value of $1,545.64 with firm fixed pricing and an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery...
- This federal contract award, valued at $2,000.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Feraheme 510 mg/17 ml vials. The contract is a Firm Fixed Price Delivery Order with a performance period extending through April 30, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Feraheme (ferumoxytol) 510 mg/17 mL vials. The $14,668.64 firm fixed-price contract has a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these injectable iron replacement therapy products to support military healthcare providers and programs. This contract is a task order under a larger DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,160.30, is for the delivery of Feraheme 510 mg/17 ml vials, a medication used to treat iron deficiency anemia. The contract is a firm fixed-price delivery order with a completion date of December 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...